Ufp Technologies (UFPT) EBIT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Ufp Technologies | 1.69 Bn | 1.67 Bn | 44.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.54% |
| Dec 31, 2025 | 34.22% |
| Sep 30, 2025 | 44.39% |
| Jun 30, 2025 | 52.05% |
| Mar 31, 2025 | 35.44% |
| Dec 31, 2024 | 26.97% |
| Sep 30, 2024 | 32.18% |
| Jun 30, 2024 | 22.26% |
| Mar 31, 2024 | 24.83% |
| Dec 31, 2023 | 18.31% |
| Sep 30, 2023 | 20.65% |
| Jun 30, 2023 | 24.62% |
| Mar 31, 2023 | 38.02% |
| Dec 31, 2022 | 39.51% |
| Sep 30, 2022 | 59.69% |
| Jun 30, 2022 | 25.43% |
| Mar 31, 2022 | 14.69% |
| Dec 31, 2021 | 15.45% |
| Sep 30, 2021 | 4.46% |
| Jun 30, 2021 | 8.16% |
| Mar 31, 2021 | 25.48% |
| Dec 31, 2020 | 13.65% |
| Sep 30, 2020 | 4.05% |
| Jun 30, 2020 | -3.00% |
| Mar 31, 2020 | 14.60% |
| Dec 31, 2019 | 22.15% |
| Sep 30, 2019 | 14.65% |
| Jun 30, 2019 | 18.71% |
| Mar 31, 2019 | 10.46% |
| Dec 31, 2018 | 0.63% |
| Sep 30, 2018 | 5.59% |
| Jun 30, 2018 | 4.12% |
| Mar 31, 2018 | -2.81% |
| Dec 31, 2017 | -14.87% |
| Sep 30, 2017 | -9.29% |
| Jun 30, 2017 | -1.81% |
| Mar 31, 2017 | -2.77% |
| Dec 31, 2016 | -11.75% |
| Sep 30, 2016 | 4.57% |
| Jun 30, 2016 | -0.58% |
| Mar 31, 2016 | -15.30% |
| Dec 31, 2015 | -10.25% |
| Sep 30, 2015 | -4.29% |
| Jun 30, 2015 | -1.03% |